THE-630
Phase 1- Indications
- Gastrointestinal stromal tumor
Company intelligence / Profile preview
Theseus Pharmaceuticals
Cambridge, Massachusetts, United Statesprnewswire.com ↗
- Ownership
- Public · THRX
- Employees
- ~38
- Development stage
- Phase 1
01
Overview
Theseus Pharmaceuticals was a clinical-stage biopharmaceutical company focused on developing next-generation small molecule pan-varient tyrosine kinase inhibitors to overcome resistance mutations in key oncogenes. Its lead program, THE‑630, targeted all classes of activating and resistance mutations in the KIT receptor for GIST and was in Phase I/II trials. Additional programs included a fourth-generation EGFR inhibitor for NSCLC and a BCR–ABL inhibitor for CML and Ph+ ALL. The company was acquired by Concentra Biosciences in February 2024.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeTyrosine kinase inhibitor (TKI)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Financials
- Market cap
- $181.5M
- Total revenue
- $0
- Enterprise value
- $-20M
Beyond the preview
Go deeper on Theseus Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Theseus Pharmaceuticals.